Subscribe to RSS
Download PDF
DOI: 10.1055/s-0037-1599354
EKG-Veränderungen bei Sportlern – Was ist wirklich gefährlich?
ECG Alterations in Athletes – What is actually dangerous?Publication History
Publication Date:
20 June 2017 (online)
Zusammenfassung
Das EKG bei Sportlern zeigt keine wesentlichen Unterschiede zu dem EKG einer gesunden Allgemeinbevölkerung. Jede elektrokardiografische Auffälligkeit bedarf der genauen Überprüfung. Lediglich Modifikationen der Erregungsbildung und Erregungsleitung sind als noch normal anzusehen. In allen anderen Fällen ist es sinnvoll, den Kardiologen oder elektrophysiologisch orientierten Kardiologen aufzusuchen.
Abstract
The ECG in athletes does not show any significant differences compared to the ECG in a healthy population. Every electrocardiographic anomaly requires accurate review. Only modifications of the excitation and conduction are rated normal. In all other cases consultation of a cardiologist or electrophysiological orientated cardiologist is advisable.
-
Literatur
- 1 Perk J, De Backer G, Gohlke H. et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012; 33: 1635-1701
- 2 Sanchis-Gomar F, Olaso-Gonzalez G, Corella D. et al. Increased average longevity among the “Tour de France” cyclists. Int J Sports Med 2011; 32: 644-647
- 3 Marijon E, Tafflet M, Antero-Jacquemin J. et al. Mortality of French participants in the Tour de France (1947–2012). Eur Heart J 2013; 34: 3145-3150
- 4 Clarke PM, Walter SJ, Hayen A. et al. Survival of the fittest: retrospective cohort study of the longevity of Olympic medallists in the modern era. BMJ 2012; 345: e8308
- 5 Sharma S, Zaidi A. Exercise-induced arrhythmogenic right ventricular cardiomyopathy: fact or fallacy?. Eur Heart J 2012; 33: 938-940
- 6 Sharma S. Presentation Titel: Sudden cardiac death in marathon running. ESC 2013, Amsterdam. Session: Protecting amateur athletes (Session Type: Clinical Seminar). FP Number: 1779. 1779
- 7 Maron BJ, Shirani J, Poliac LC. et al. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 1996; 276: 199-204
- 8 DʼSilva A, Papadakis M. Sudden Cardiac Death in Athletes. Eur Cardiol Rev 2015; 10: 48-50
- 9 Corrado D, Schmied C, Basso C. et al. Risk of sports: do we need a pre-participation screening for competitive and leisure athletes?. Euro Heart J 2011; 32: 934-944
- 10 Rowin EJ, Maron BJ, Appelbaum E. et al. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy. Am J Cardiol 2012; 110: 1027-1032
- 11 Drezner JA, Ackerman MJ, Anderson J. et al. Electrocardiographic interpretation in athletes: the ‘Seattle criteria’. Br J Sports Med 2013; 47: 122-124
- 12 Chandra N, Bastiaenen R, Papadakis M. et al. Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. J Am Coll Cardiol 2013; 61: 1027-1040
- 13 Maron BJ. Distinguishing hypertrophic cardiomyopathy from athleteʼs heart: a clinical problem of increasing magnitude and significance. Heart 2005; 91: 1380-1382
- 14 Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace 2009; 11: 1156-1159
- 15 Kooperman P, Nuyens D, Garweg C. et al. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation. Europace 2011; 13: 1386-1393